Department of Orthopaedic Surgery, Nihon University School of Medicine, 30-1 Oyaguchi Kami-cho, Itabashi-ku, Tokyo, 173-8610, Japan.
Osteoporos Int. 2018 May;29(5):1211-1215. doi: 10.1007/s00198-018-4425-9. Epub 2018 Feb 23.
Surgical treatment of multiple vertebral fractures in patients with glucocorticoid-induced osteoporosis is difficult because of a high rate of secondary fracture postoperatively. A case is described in which initial treatment with teriparatide to improve osteoporosis followed by treatment of kyphosis with correction fusion achieved a favorable outcome.
Secondary fracture frequently occurs after treatment of vertebral fracture with vertebroplasty and balloon kyphoplasty in patients with glucocorticoid-induced osteoporosis, but effective treatment of multiple vertebral fractures has rarely been reported. Thus, a treatment of kyphosis following multiple vertebral fractures associated with glucocorticoid-induced osteoporosis is required.
The patient was a 24-year-old woman diagnosed with glucocorticoid-induced osteoporosis who was under treatment with oral alendronate, vitamin D, and elcatonin injection. Secondary multiple vertebral fractures occurred despite these treatments and low back pain gradually aggravated.
Vertebroplasty or balloon kyphoplasty was not performed in the early phase. Instead, treatment with teriparatide was used for initial improvement of osteoporosis. Kyphosis in the center of the residual thoracolumbar junction was then treated with posterior correction fusion. At 2 years after surgery, the corrected position has been maintained and no new fracture has occurred.
There is no established method for treatment of multiple vertebral fractures caused by glucocorticoid-induced osteoporosis. Initial treatment with teriparatide to improve osteoporosis followed by treatment of kyphosis with correction fusion may result in a more favorable outcome.
由于术后继发性骨折发生率高,糖皮质激素诱导性骨质疏松症患者的多处椎体骨折的手术治疗较为困难。本文描述了 1 例患者,先使用特立帕肽治疗骨质疏松症,再使用矫正融合治疗后凸畸形,获得了良好的效果。
在糖皮质激素诱导性骨质疏松症患者中,经皮椎体成形术和球囊椎体后凸成形术治疗椎体骨折后,常发生继发性骨折,但鲜有报道有效治疗多处椎体骨折。因此,需要治疗糖皮质激素诱导性骨质疏松症伴多发椎体骨折所致的后凸畸形。
患者为 24 岁女性,诊断为糖皮质激素诱导性骨质疏松症,正在接受口服阿仑膦酸钠、维生素 D 和鲑鱼降钙素注射治疗。尽管进行了这些治疗,但仍发生了继发性多处椎体骨折,且腰痛逐渐加重。
早期未行椎体成形术或球囊后凸成形术,而是使用特立帕肽进行初始骨质疏松症治疗。然后对残留胸腰段交界处的后凸畸形采用后路矫正融合治疗。术后 2 年,矫正位置保持良好,未发生新骨折。
对于糖皮质激素诱导性骨质疏松症引起的多处椎体骨折,目前尚无既定的治疗方法。先用特立帕肽改善骨质疏松症,再用矫正融合治疗后凸畸形,可能会取得更好的效果。